Resources

COVID-19 Vaccine Certificates: Key Considerations for the Ontario Context

Product: — Science Table

Public Health & Implementation Public Health Policy Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: July 21, 2021

Healthcare workers’ perceptions and experiences of communicating with people over 50 years of age about vaccination: a qualitative evidence synthesis

Product: — Cochrane Library

Communication Practices Communications & Media Vaccine Vaccines & Immunity

www.cochranelibrary.com Last Updated: July 20, 2021

Also available in Français

Ontario’s Community-Dwelling Older Adults Who Remain Unvaccinated Against COVID-19

Product: — Science Table

Barriers to Access Health Inequities Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: July 16, 2021

Effectiveness of Rehabilitation Interventions for People with Long COVID

Product: — Evidence Synthesis Network

Long Covid Signs & Symptoms

esnetwork.ca Last Updated: July 10, 2021

Strategies to Support Ontarians’ Capability, Opportunity, and Motivation for COVID‑19 Vaccination

Product: — Science Table

About Coronavirus Epidemiology Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: June 23, 2021

Guidance and Jurisdictional Evidence Regarding The Use of Vaccine Passports

Product: — Evidence Synthesis Network

Public Health Policy Regulation & Policy Vaccine Vaccines & Immunity

esnetwork.ca Last Updated: June 21, 2021

Effectiveness of Incentives to Promote COVID‑19 Vaccine Uptake

Product: — Evidence Synthesis Network

Vaccine Vaccines & Immunity

esnetwork.ca Last Updated: June 17, 2021

COVID-19 Vaccination for People with Disabilities

Product: — Science Table

Health Status Public Health & Implementation Vaccine Vaccines & Immunity Vulnerable Groups Vulnerable Sub-populations

covid19-sciencetable.ca Last Updated: June 15, 2021

COVID-19 Post-Vaccine Risks, Activities, and Public Health Measures

Product: — Evidence Synthesis Network

Public Health Policy Regulation & Policy Vaccine Vaccines & Immunity

esnetwork.ca Last Updated: May 12, 2021

Risk of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) following the AstraZeneca/COVISHIELD Adenovirus Vector COVID‑19 Vaccines

Product: — Science Table

Disease Mechanism Infectious Diseases & Clinical Care Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: May 11, 2021